Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Oct 27;335(7625):865.
doi: 10.1136/bmj.39341.608519.BE. Epub 2007 Oct 22.

Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine

Affiliations
Randomized Controlled Trial

Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine

Nirmal S Raveendran et al. BMJ. .

Abstract

Objective: To compare the effect of intramuscular olanzapine with intramuscular haloperidol plus promethazine on rapid tranquillisation of agitated or violent people with mental illness.

Design: Pragmatic, allocation concealed, randomised controlled trial.

Setting: Emergency services of a general hospital psychiatry department in Vellore, south India.

Participants: 300 adults with agitated or violent behaviour as a result of mental illness; 150 randomised to intramuscular olanzapine and 150 randomised to intramuscular haloperidol plus promethazine.

Interventions: Open treatment with intramuscular olanzapine or intramuscular haloperidol plus promethazine.

Main outcome measures: Primary outcome was proportion of patients who were tranquil or asleep at 15 minutes and 240 minutes. Secondary outcomes were proportion of patients who were tranquil, asleep, restrained, absconding, or clinically improved at 15, 30, 60, 120, and 240 minutes; additional medical interventions and adverse effects over four hours; and compliance with oral drugs and adverse effects over two weeks.

Results: Of 300 people randomised to receive either intramuscular olanzapine or intramuscular haloperidol plus promethazine, follow-up data were available for primary outcomes for 298 (99%). Both treatments resulted in similar proportions of people being tranquil or asleep at 15 minutes (olanzapine 131/150 (87%), haloperidol plus promethazine 136/150 (91%); relative risk 0.96, 95% confidence interval 0.34 to 1.47) and 240 minutes (olanzapine 144/150 (96%), haloperidol plus promethazine 145/150 (97%); relative risk 0.99, 0.95 to 1.03). However, more people given olanzapine than those given haloperidol plus promethazine required additional drugs over four hours (65/150 (43%) v 31/150 (21%); relative risk 2.07, 1.43 to 2.97). Adverse effects were uncommon with both treatments.

Conclusions: Intramuscular olanzapine and intramuscular haloperidol plus promethazine were effective at rapidly tranquillising or sedating agitated or violent patients with mental illness but the combination resulted in fewer additional medical interventions within four hours of intervention.

Trial registration: Clinical trials NCT00455234 [ClinicalTrials.gov].

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

None
Patient flow through trial

Comment in

References

    1. Reddy MV, Chandrasekhar CR. Prevalence of mental and behavioural disorders in India: a metaanalysis. Ind J Psychiatry 1998;40:149-57. - PMC - PubMed
    1. McAllister-Williams RH, Ferrier IN. Rapid tranquillisation: time for a reappraisal of options for parenteral therapy. Br J Psychiatry 2002;180:485-9. - PubMed
    1. Tardiff K, Koenigsberg HW. Assaultive behavior among psychiatric outpatients. Am J Psychiatry 1985;142:960-3. - PubMed
    1. Kaplan HI, Sadock BJ, Grebb JA. Kaplan and Sadock's synopsis of psychiatry Baltimore, MD: Williams & Wilkins, 1994
    1. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper J, et al. Schizophrenia: manifestations, incidence and course in different cultures. A world health organization ten-country study. Psychol Med Monogr Suppl 1992;20:1-97. - PubMed

Publication types

Associated data